Skip to main content
SpringerLink
Log in

Homocystinuria and Cobalamin Disorders

  • Chapter
  • First Online:
Nutrition Management of Inherited Metabolic Diseases

  • 996 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carson NA, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child. 1962;37:505–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science. 1964;143(3613):1443–5.

    Article  CAS  PubMed  Google Scholar 

  3. Andria G, Fowler B, Sebastio G. Disorders of sulfur amino acid metabolism. In: Saudubray JM, Walter JH, editors. Inborn metabolic diseases: diagnosis and treatment. 5th ed. Berlin: Springer-Verlag; 2012.

    Google Scholar 

  4. Nyhan WL, Barshop BA, Ozand PT. Homocystinuria. In: Atlas of metabolic diseases. 2nd ed. London: Hodder Arnold; 2005.

    Google Scholar 

  5. Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis. 2011;34(1):75–81.

    Article  CAS  PubMed  Google Scholar 

  6. Morris AA, Kozich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40(1):49–74.

    Article  CAS  PubMed  Google Scholar 

  7. Huemer M, Burer C, Jesina P, Kozich V, Landolt MA, Suormala T, et al. Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data. J Inherit Metab Dis. 2015;38(5):957–67.

    Article  CAS  PubMed  Google Scholar 

  8. Schiff M, Blom HJ. Treatment of inherited homocystinurias. Neuropediatrics. 2012;43(6):295–304.

    Article  CAS  PubMed  Google Scholar 

  9. Pullin CH, Bonham JR, McDowell IF, Lee PJ, Powers HJ, Wilson JF, et al. Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria. J Inherit Metab Dis. 2002;25(2):107–18.

    Article  CAS  PubMed  Google Scholar 

  10. Gus PI, Pilati NP, Schoenardie BO, Marinho DR. Classic homocystinuria and keratoconus: a case report. Arq Bras Oftalmol. 2018;81(4):336–8.

    Article  PubMed  Google Scholar 

  11. Weber DR, Coughlin C, Brodsky JL, Lindstrom K, Ficicioglu C, Kaplan P, et al. Low bone mineral density is a common finding in patients with homocystinuria. Mol Genet Metab. 2016;117(3):351–4.

    Article  CAS  PubMed  Google Scholar 

  12. Abbott MH, Folstein SE, Abbey H, Pyeritz RE. Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet. 1987;26(4):959–69.

    Article  CAS  PubMed  Google Scholar 

  13. Almuqbil MA, Waisbren SE, Levy HL, Picker JD. Revising the psychiatric phenotype of homocystinuria. Genet Med. 2019;21(8):1827–31.

    Article  PubMed  Google Scholar 

  14. Sasai H, Shimozawa N, Asano T, Kawamoto N, Yamamoto T, Kimura T, et al. Successive MRI findings of reversible cerebral white matter lesions in a patient with cystathionine beta-synthase deficiency. Tohoku J Exp Med. 2015;237(4):323–7.

    Google Scholar 

  15. Li CQ, Barshop BA, Feigenbaum A, Khanna PC. Brain magnetic resonance imaging findings in poorly controlled homocystinuria. J Radiol Case Rep. 2018;12(1):1–8.

    PubMed  PubMed Central  Google Scholar 

  16. Woods E, Dawson C, Senthil L, Geberhiwot T. Cerebral venous thrombosis as the first presentation of classical homocystinuria in an adult patient. BMJ Case Rep. 2017;2017

    Google Scholar 

  17. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, et al. Coexistence of hereditary homocystinuria and factor V Leiden–effect on thrombosis. N Engl J Med. 1996;334(12):763–8.

    Article  CAS  PubMed  Google Scholar 

  18. Kluijtmans LA, Boers GH, Verbruggen B, Trijbels FJ, Novakova IR, Blom HJ. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis. Blood. 1998;91(6):2015–8.

    Article  CAS  PubMed  Google Scholar 

  19. De Franchis R, Sperandeo MP, Sebastio G, Andria G. Clinical aspects of cystathionine beta-synthase deficiency: how wide is the spectrum? The Italian Collaborative Study Group on Homocystinuria. Eur J Pediatr. 1998;157(Suppl 2):S67–70.

    Article  PubMed  Google Scholar 

  20. Muacevic-Katanec D, Kekez T, Fumic K, Baric I, Merkler M, Jakic-Razumovic J, et al. Spontaneous perforation of the small intestine, a novel manifestation of classical homocystinuria in an adult with new cystathionine beta-synthetase gene mutations. Coll Antropol. 2011;35(1):181–5.

    CAS  PubMed  Google Scholar 

  21. Al Humaidan M, Al Sharkawy I, Al Sanae A, Al Refaee F. Homocystinuria with lower gastrointestinal bleeding: first case report. Med Princ Pract. 2013;22(5):500–2.

    Article  PubMed  Google Scholar 

  22. Snyderman SE. Liver failure and neurologic disease in a patient with homocystinuria. Mol Genet Metab. 2006;87(3):210–2.

    Article  CAS  PubMed  Google Scholar 

  23. Gupta P, Goyal S, Grant PE, Fawaz R, Lok J, Yager P, et al. Acute liver failure and reversible leukoencephalopathy in a pediatric patient with homocystinuria. J Pediatr Gastroenterol Nutr. 2010;51(5):668–71.

    Article  PubMed  Google Scholar 

  24. Lorenzini M, Guha N, Davison JE, Pitcher A, Pandya B, Kemp H, et al. Isolated aortic root dilation in homocystinuria. J Inherit Metab Dis. 2018;41(1):109–15.

    Article  CAS  PubMed  Google Scholar 

  25. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37(1):1–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Janosik M, Sokolova J, Janosikova B, Krijt J, Klatovska V, Kozich V. Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J Pediatr. 2009;154(3):431–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Skovby F, Gaustadnes M. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab. 2010;99(1):1–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Magner M, Krupkova L, Honzik T, Zeman J, Hyanek J, Kozich V. Vascular presentation of cystathionine beta-synthase deficiency in adulthood. J Inherit Metab Dis. 2011;34(1):33–7.

    Article  CAS  PubMed  Google Scholar 

  29. Moghadasian MH, McManus BM, Frohlich JJ. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background. Arch Intern Med. 1997;157(20):2299–308.

    Article  CAS  PubMed  Google Scholar 

  30. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274(13):1049–57.

    Article  CAS  PubMed  Google Scholar 

  31. Yang Q, He GW. Imbalance of homocysteine and H2S: significance, mechanisms, and therapeutic promise in vascular injury. Oxidative Med Cell Longev. 2019;2019:7629673.

    Google Scholar 

  32. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91(14):6369–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996;98(1):5–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Vanzin CS, Biancini GB, Sitta A, Wayhs CA, Pereira IN, Rockenbach F, et al. Experimental evidence of oxidative stress in plasma of homocystinuric patients: a possible role for homocysteine. Mol Genet Metab. 2011;104(1–2):112–7.

    Article  CAS  PubMed  Google Scholar 

  35. Vanzin CS, Manfredini V, Marinho AE, Biancini GB, Ribas GS, Deon M, et al. Homocysteine contribution to DNA damage in cystathionine beta-synthase-deficient patients. Gene. 2014;539(2):270–4.

    Article  CAS  PubMed  Google Scholar 

  36. Richard E, Gallego-Villar L, Rivera-Barahona A, Oyarzabal A, Perez B, Rodriguez-Pombo P, et al. Altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Oxidative Med Cell Longev. 2018;2018:1246069.

    Article  CAS  Google Scholar 

  37. Behera J, Kelly KE, Voor MJ, Metreveli N, Tyagi SC, Tyagi N. Hydrogen sulfide promotes bone homeostasis by balancing inflammatory cytokine signaling in CBS-deficient mice through an epigenetic mechanism. Sci Rep. 2018;8(1):15226.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Majumder A, Singh M, Behera J, Theilen NT, George AK, Tyagi N, et al. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury. Am J Physiol Cell Physiol. 2018;315(5):C609–C22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Bissonnette B, Luginbuehl I, Marciniak B. Homocystinuria in syndromes: rapid recognition and perioperative implications. New York: McGraw Hill Companies; 2006.

    Google Scholar 

  40. Mudd SH, Levy HL, Kraus JP. Disorders of transsulferation. Metabolic and molecular basis of inherited disease. New York: McGraw Hill Companies; 2001.

    Google Scholar 

  41. Keating AK, Freehauf C, Jiang H, Brodsky GL, Stabler SP, Allen RH, et al. Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria. Mol Genet Metab. 2011;103(4):330–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Poloni S, Schweigert Perry ID, D'Almeida V, Schwartz IV. Does phase angle correlate with hyperhomocysteinemia? A study of patients with classical homocystinuria. Clin Nutr. 2013;32(3):479–80.

    Article  CAS  PubMed  Google Scholar 

  43. Orendac M, Zeman J, Stabler SP, Allen RH, Kraus JP, Bodamer O, et al. Homocystinuria due to cystathionine beta-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis. 2003;26(8):761–73.

    Article  CAS  PubMed  Google Scholar 

  44. Echaniz-Laguna A, Mourot-Cottet R, Noel E, Chanson JB. Regressive pyridoxine-induced sensory neuronopathy in a patient with homocystinuria. BMJ Case Rep. 2018;2018

    Google Scholar 

  45. Bendich A, Cohen M. Vitamin B6 safety issues. Ann N Y Acad Sci. 1990;585:321–30.

    Article  CAS  PubMed  Google Scholar 

  46. Baric I, Fowler B. Sulphur amino acids. In: Blau N, et al., editors. Physician’s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases. Heidelberg: Springer-Verlag; 2014. p. 43.

    Google Scholar 

  47. Lawson-Yuen A, Levy HL. The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab. 2006;88(3):201–7.

    Article  CAS  PubMed  Google Scholar 

  48. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis. 1997;20(2):295–300.

    Article  CAS  PubMed  Google Scholar 

  49. Singh RH, Kruger WD, Wang L, Pasquali M, Elsas LJ 2nd. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genet Med. 2004;6(2):90–5.

    Article  CAS  PubMed  Google Scholar 

  50. Yaghmai R, Kashani AH, Geraghty MT, Okoh J, Pomper M, Tangerman A, et al. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet. 2002;108(1):57–63.

    Article  PubMed  Google Scholar 

  51. Devlin AM, Hajipour L, Gholkar A, Fernandes H, Ramesh V, Morris AA. Cerebral edema associated with betaine treatment in classical homocystinuria. J Pediatr. 2004;144(4):545–8.

    Article  CAS  PubMed  Google Scholar 

  52. Valayannopoulos V, Schiff M, Guffon N, Nadjar Y, Garcia-Cazorla A, Martinez-Pardo Casanova M, et al. Betaine anhydrous in homocystinuria: results from the RoCH registry. Orphanet J Rare Dis. 2019;14(1):66.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Bublil EM, Majtan T, Park I, Carrillo RS, Hulkova H, Krijt J, et al. Enzyme replacement with PEGylated cystathionine beta-synthase ameliorates homocystinuria in murine model. J Clin Invest. 2016;126(6):2372–84.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Koeberl DD. Vision of correction for classic homocystinuria. J Clin Invest. 2016;126(6):2043–4.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Majtan T, Park I, Cox A, Branchford BR, di Paola J, Bublil EM, et al. Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy. FASEB J. 2019;33(11):12477–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Lin NC, Niu DM, Loong CC, Hsia CY, Tsai HL, Yeh YC, et al. Liver transplantation for a patient with homocystinuria. Pediatr Transplant. 2012;16(7):E311–4.

    Article  PubMed  Google Scholar 

  57. Koblin DD. Homocystinuria and administration of nitrous oxide. J Clin Anesth. 1995;7(2):176.

    Article  CAS  PubMed  Google Scholar 

  58. Badner NH, Beattie WS, Freeman D, Spence JD. Nitrous oxide-induced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg. 2000;91(5):1073–9.

    CAS  PubMed  Google Scholar 

  59. Asghar A, Ali FM. Anaesthetic management of a young patient with homocystinuria. J Coll Physicians Surg Pak. 2012;22(11):720–2.

    PubMed  Google Scholar 

  60. Lowe S, Johnson DA, Tobias JD. Anesthetic implications of the child with homocystinuria. J Clin Anesth. 1994;6(2):142–4.

    Article  CAS  PubMed  Google Scholar 

  61. Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis. 1998;21(7):738–47.

    Article  CAS  PubMed  Google Scholar 

  62. Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, et al. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001;21(12):2080–5.

    Article  CAS  PubMed  Google Scholar 

  63. Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011;157C(1):33–44.

    Article  PubMed  CAS  Google Scholar 

  64. Watkins D, Rosenblatt DS, Fowler B. Disorders of cobalamin and folate transport and metabolism. In: Saudubray JM, Baumgartner M, Walter J, editors. Inborn metabolic diseases: diagnosis and treatment. 6th ed. Berlin: Springer-Verlag; 2016. p. 385–99.

    Chapter  Google Scholar 

  65. Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21–48.

    Article  CAS  PubMed  Google Scholar 

  66. Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis. 2011;34(1):127–35.

    Article  CAS  PubMed  Google Scholar 

  67. Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis. 2012;35(1):91–102.

    Article  CAS  PubMed  Google Scholar 

  68. Goodman SI, Moe PG, Hammond KB, Mudd SH, Uhlendorf BW. Homocystinuria with methylmalonic aciduria: two cases in a sibship. Biochem Med. 1970;4(5):500–15.

    Article  CAS  PubMed  Google Scholar 

  69. Yu HC, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, et al. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. Am J Hum Genet. 2013;93(3):506–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Scalais E, Osterheld E, Weitzel C, De Meirleir L, Mataigne F, Martens G, et al. X-linked cobalamin disorder (HCFC1) mimicking nonketotic hyperglycinemia with increased both cerebrospinal fluid glycine and methylmalonic acid. Pediatr Neurol. 2017;71:65–9.

    Article  PubMed  Google Scholar 

  71. Gerard M, Morin G, Bourillon A, Colson C, Mathieu S, Rabier D, et al. Multiple congenital anomalies in two boys with mutation in HCFC1 and cobalamin disorder. Eur J Med Genet. 2015;58(3):148–53.

    Article  CAS  PubMed  Google Scholar 

  72. Manoli I, Myles JG, Sloan JL, Carrillo-Carrasco N, Morava E, Strauss KA, et al. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency. Genet Med. 2016;18(4):396–404.

    Article  CAS  PubMed  Google Scholar 

  73. Weisfeld-Adams JD, Bender HA, Miley-Akerstedt A, Frempong T, Schrager NL, Patel K, et al. Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013;110(3):241–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado School of Medicine, Aurora, CO, USA

    Janet A. Thomas

Authors
  1. Janet A. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janet A. Thomas .

Editor information

Editors and Affiliations

  1. Children’s Hospital Colorado, University of Colorado Hospital, Aurora, CO, USA

    Laurie E. Bernstein

  2. Met Ed Co, Boulder, CO, USA

    Fran Rohr

  3. Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA

    Sandy van Calcar

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Thomas, J.A. (2022). Homocystinuria and Cobalamin Disorders. In: Bernstein, L.E., Rohr, F., van Calcar, S. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-94510-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94510-7_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94509-1

  • Online ISBN: 978-3-030-94510-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation